Literature DB >> 1963066

Time trends and survival in patients presented for surgery with non-small-cell lung cancer 1969-1985.

C Jie1, A M Wever, H A Huysmans, H C Franken, J Wever-Hess, J Hermans.   

Abstract

All evaluable patients (n = 920) with primary non-small-cell lung cancer (NSCLC) who were presented for surgery in our hospital between 1969 and 1985 were reviewed as to histological findings, postoperative stage, age group and surgical procedure. Time trend analyses showed a significant increase over time in the proportion of adenocarcinomas (p = 0.025) and in the proportion of the elderly (greater than or equal to 70 years; p = 0.014). The 5-year survival rates by year of operation showed no improvement at all over time; on the contrary they showed a decline, which however only reached significance for patients who underwent pneumonectomy (p = 0.034). It is noted that the overall survival curves up to 5 years showed no significant differences between patients with adenocarcinoma and patients with squamous cell carcinoma, or between patients aged 70 years or more and patients aged 60-69 years. Despite expanded preoperative diagnostic techniques and developments in surgical treatment, no improvement in the survival after surgery for NSCLC over the period 1969-1985 could be established.

Entities:  

Mesh:

Year:  1990        PMID: 1963066     DOI: 10.1016/1010-7940(90)90057-7

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  2 in total

1.  Analysis of survival for lung cancer resections cases with fuzzy and soft set theory in surgical decision making.

Authors:  José Carlos R Alcantud; Gonzalo Varela; Beatriz Santos-Buitrago; Gustavo Santos-García; Marcelo F Jiménez
Journal:  PLoS One       Date:  2019-06-19       Impact factor: 3.240

2.  Current Trends of Lung Cancer Surgery and Demographic and Social Factors Related to Changes in the Trends of Lung Cancer Surgery: An Analysis of the National Database from 2010 to 2014.

Authors:  Samina Park; In Kyu Park; Eung Re Kim; Yoohwa Hwang; Hyun Joo Lee; Chang Hyun Kang; Young Tae Kim
Journal:  Cancer Res Treat       Date:  2016-07-18       Impact factor: 4.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.